[go: up one dir, main page]

SE9600141D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
SE9600141D0
SE9600141D0 SE9600141A SE9600141A SE9600141D0 SE 9600141 D0 SE9600141 D0 SE 9600141D0 SE 9600141 A SE9600141 A SE 9600141A SE 9600141 A SE9600141 A SE 9600141A SE 9600141 D0 SE9600141 D0 SE 9600141D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
SE9600141A
Other languages
Swedish (sv)
Inventor
Lars-Erik Briggner
Katarina Bystroem
Edib Jakupovic
Eva Trofast
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9600141A priority Critical patent/SE9600141D0/en
Publication of SE9600141D0 publication Critical patent/SE9600141D0/en
Priority to US08/606,655 priority patent/US5874063A/en

Links

SE9600141A 1991-04-11 1996-01-16 Pharmaceutical formulation SE9600141D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE9600141A SE9600141D0 (en) 1996-01-16 1996-01-16 Pharmaceutical formulation
US08/606,655 US5874063A (en) 1991-04-11 1996-02-26 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9600141A SE9600141D0 (en) 1996-01-16 1996-01-16 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
SE9600141D0 true SE9600141D0 (en) 1996-01-16

Family

ID=20401032

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9600141A SE9600141D0 (en) 1991-04-11 1996-01-16 Pharmaceutical formulation

Country Status (1)

Country Link
SE (1) SE9600141D0 (en)

Similar Documents

Publication Publication Date Title
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
NO954486D0 (en) Pharmaceutical formulation basis
DE69525148D1 (en) PHARMACEUTICAL FORMULATION
BR9610153A (en) Pharmaceutical formulations
BR9611626A (en) Pharmaceutical formulations
BR9611367A (en) Stable lyophilized pharmaceutical formulation
ID25533A (en) 2-METHYL-TIENO-BENZODIAZEPIN FORMULATION
ID18352A (en) PHARMACEUTICAL COMPOSITIONS
BR9610396A (en) Pharmaceutical formulation
FI991302A7 (en) Improved pharmaceutical compositions
ID16781A (en) PHARMACEUTICAL FORMULATIONS
BR9507768A (en) Pharmaceutical composition
ID29294A (en) PHARMACEUTICAL COMPOSITION
TR199501082A2 (en) Pharmaceutical formulations.
ITMI941169A0 (en) PHARMACEUTICAL FORMULATIONS
ID30032A (en) PHARMACEUTICAL FORMULATION
ID18698A (en) PHARMACEUTICAL COMPOSITION
ID25857A (en) PHARMACEUTICAL COMPOSITION
FI973230A0 (en) New pharmaceutical formulation
FI951155A7 (en) Pharmaceutical preparation
FI961364L (en) Drug composition
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION
ID23531A (en) PHARMACEUTICAL COMPOSITION
SE9600141D0 (en) Pharmaceutical formulation
SE9404195D0 (en) New pharmaceutical formulation